Security Snapshot

ASSEMBLY BIOSCIENCES, INC. - Common Stock (ASMB) Institutional Ownership

CUSIP: 045396207

13F Institutional Holders and Ownership History from Q1 2024 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

68

Shares (Excl. Options)

16.19MFull value: 16,190,929 · shares · 30 Sep 2026

Price

$23.49

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-1,071,730
Value change
-$27,743,228
Number of holders
68
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
20,434,758
SEC-reported price per share
$21.19
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock is tracked under CUSIP 045396207.
  • 68 institutions reported positions in Q3 2026.
  • 8 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 91 to 68 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $514.79MFull value: $514,785,552 · USD · 30 Jun 2026
    to
    $379.91MFull value: $379,910,350 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 68 institutions filings for Q3 2026.

Open SEC evidence

Security key

045396207

13F reference period

Q3 2026

13F holders

68

13D/G owners

8

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
8
Security
ASMB
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Commodore Capital LP 9.9% $29,281,576 1,615,981 Commodore Capital LP 08 Aug 2025
FARALLON CAPITAL MANAGEMENT, L.L.C. 8.1% $46,484,972 1,604,590 Farallon Capital Management, L.L.C. 30 Jun 2026
Paradigm Biocapital Advisors LP 7.8% $45,012,080 1,553,748 Paradigm BioCapital Advisors LP 30 Jun 2026
RA CAPITAL MANAGEMENT, L.P. 9.5% $28,392,908 1,530,615 RA Capital Management, L.P. 11 Aug 2025
Farallon Capital Partners, L.P. 7.8% +7.1% $38,963,707 +$2,763,919 1,227,590 +7.6% Dapice Joshua J. 31 Dec 2025
Janus Henderson Group Ltd. 3.3% -51% $15,840,411 -$16,094,573 674,347 -50% JANUS HENDERSON GROUP Ltd. 30 Sep 2026
Schornstein Alexander 3.5% -65% $10,082,352 -$3,424,144 543,523 -25% Alexander Schornstein 11 Aug 2025
ARMISTICE CAPITAL, LLC 10% $5,252,553 289,876 Armistice Capital, LLC 30 Jun 2025
As of 30 Sep 2026, 68 institutional investors reported holding
16.19MFull value: 16,190,929 · shares · 30 Sep 2026
shares of ASSEMBLY BIOSCIENCES, INC. - Common Stock (ASMB). This represents 79% of the company’s total
20.43MFull value: 20,434,758 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
75%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
GILEAD SCIENCES, INC. 24% 4,977,089 0% 8% $116,911,821
FARALLON CAPITAL MANAGEMENT, L.L.C. 7.9% 1,604,590 0% 0.2% $37,691,819
Paradigm Biocapital Advisors LP 7.6% 1,553,748 0% 0.73% $36,497,541
RA CAPITAL MANAGEMENT, L.P. 5% 1,020,410 0% 0.24% $23,969,431
Parkman Healthcare Partners LLC 3.9% 796,256 +10% 1.7% $18,704,053
VANGUARD CAPITAL MANAGEMENT LLC 3% 602,932 +7.9% 0% $14,162,873
STATE STREET CORP 2.7% 559,590 +225% 0% $13,144,769
MILLENNIUM MANAGEMENT LLC 2.4% 490,137 +64% 0.01% $11,513,318
Commodore Capital LP 2.3% 461,922 -67% 0.84% $10,850,548
Seven Fleet Capital Management LP 2% 417,441 -3.6% 1.9% $9,805,689
Point72 Asset Management, L.P. 1.8% 362,728 -21% 0.01% $8,520,481
GEODE CAPITAL MANAGEMENT, LLC 1.8% 361,152 +29% 0% $8,485,000
Schonfeld Strategic Advisors LLC 1.1% 228,002 -5.8% 0.03% $5,355,765
DV EQUITIES, LLC 1.1% 226,415 0% 1% $5,318,488
Squadron Capital Management LLC 1.1% 225,000 +41% 1.6% $5,285,250
GOLDMAN SACHS GROUP INC 0.94% 191,747 +39% 0% $4,504,137
B Group, Inc. 0.86% 175,706 0% 2.5% $4,127,334
Janus Henderson Group Ltd. 0.8% 164,142 -81% 0% $3,849,951
Woodline Partners LP 0.74% 150,780 0% 0.01% $3,541,822
Driehaus Capital Management LLC 0.63% 128,307 -14% 0.02% $3,013,931
VANGUARD PORTFOLIO MANAGEMENT LLC 0.61% 124,931 +37% 0% $2,934,629
Qube Research & Technologies Ltd 0.56% 114,422 +122% 0% $2,687,773
FRANKLIN TEMPLETON INC 0.55% 113,200 0% 0% $2,249,284
RENAISSANCE TECHNOLOGIES LLC 0.55% 112,017 +184% 0% $2,631,279
VANGUARD FIDUCIARY TRUST CO 0.47% 95,578 +29% 0% $2,245,127

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
11
Headline period
Q3 2026
Rows shown
1-11 of 11
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 16,190,929 $379,910,350 -$27,743,228 $23.49 68
2026 Q2 18,732,803 $514,785,552 +$141,037,731 $27.48 91
2026 Q1 13,568,603 $376,381,234 -$6,937,135 $27.75 74
2025 Q4 13,724,214 $466,681,283 +$45,981,788 $34.01 69
2025 Q3 12,244,439 $313,500,808 +$233,088,276 $25.60 56
2025 Q2 3,148,479 $57,049,319 +$415,033 $18.12 33
2025 Q1 3,175,639 $30,358,304 -$551,384 $9.56 36
2024 Q4 3,185,761 $50,270,587 -$3,179,725 $15.78 35
2024 Q3 1,026,987 $15,540,749 -$2,242,995 $15.14 30
2024 Q2 1,175,256 $16,110,171 +$7,242,756 $13.72 27
2024 Q1 647,283 $8,609,474 +$8,609,474 $13.30 24
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .